Taxing JVs in India

In their article, Phoenix Legal’s Kripi Kathuria and Ankur Verma discuss why the pharmaceutical industry in India is attracting interest from investors worldwide, noting amongst other things “ever-increasing returns, lowering risk and anticipated multifold growth”.

The Companies (Amendment) Act, 2015 (Amendment Act), which aims to amend the rigidities of the Companies Act, 2013 (Act), has ...